Effectiveness of Low-frequency RTMS and Intensive Speech Therapy in Poststroke Patients with Aphasia: a Pilot Study Based on Evaluation by FMRI in Relation to Type of Aphasia
Overview
Affiliations
Aim: To assess the safety and clinical efficacy of low-frequency repetitive transcranial magnetic stimulation (LF-rTMS) combined with intensive speech therapy (ST) in poststroke patients with aphasia.
Subjects And Methods: Twenty-four patients with left-hemispheric stroke and aphasia were subjected. During 11-day hospitalization, each patient received 10 treatment sessions consisting of 40-min 1-Hz LF-rTMS and 60-min intensive ST, excluding Sundays. The scalp area for stimulation was selected based on the findings of fMRI with language tasks and the type of aphasia. LF-rTMS was applied to the inferior frontal gyrus (IGF) for patients with nonfluent aphasia and to the superior temporal gyrus (STG) for patients with fluent aphasia.
Results: On pretreatment fMRI, the most activated areas were in the left hemisphere (n=16) and right hemisphere (n=8). The types of aphasia were nonfluent (n=14) and fluent (n=10). The LF-rTMS was applied to the right STG (n=5), left STG (n=5), right IFG (n=11) and left IFG (n=3). Nonfluent aphasic patients showed significant improvement of auditory comprehension, reading comprehension and repetition. Fluent aphasic patients showed significant improvement in spontaneous speech only.
Conclusion: The fMRI with aphasic type-based therapeutic LF-rTMS/intensive ST for chronic aphasia seems feasible and a potentially useful neurorehabilitative protocol.
Targeted neurorehabilitation strategies in post-stroke aphasia.
Shah-Basak P, Boukrina O, Li X, Jebahi F, Kielar A Restor Neurol Neurosci. 2023; 41(3-4):129-191.
PMID: 37980575 PMC: 10741339. DOI: 10.3233/RNN-231344.
Brady M, Ali M, VandenBerg K, Williams L, Williams L, Abo M Aphasiology. 2023; 34(2):137-157.
PMID: 37560459 PMC: 7614912. DOI: 10.1080/02687038.2019.1643003.
Zhou L, Jin Y, Wu D, Cun Y, Zhang C, Peng Y Front Neurosci. 2023; 17:1177283.
PMID: 37534033 PMC: 10390744. DOI: 10.3389/fnins.2023.1177283.
Sakurai Y, Abo M, Terajima S, Ikeda S, Ohara K, Hada T J Med Case Rep. 2023; 17(1):285.
PMID: 37420275 PMC: 10329296. DOI: 10.1186/s13256-023-03992-0.
Chino T, Kinoshita S, Abo M Prog Rehabil Med. 2023; 8:20230005.
PMID: 36866154 PMC: 9970844. DOI: 10.2490/prm.20230005.